Clinical trial
Efficacy of SU 011248 in Head And Neck Carcinoma
NCT00408252 · Cliniques universitaires Saint-Luc- Université Catholique de Louvain, Other · Terminated
Key facts
| NCT number | NCT00408252 |
|---|---|
| Title | Efficacy of SU 011248 in Head And Neck Carcinoma |
| Official title | A Phase II Study Of Su011248 In Patients With Recurrent And/Or Metastatic Squamous Head And Neck Carcinoma. |
| Lead sponsor | Cliniques universitaires Saint-Luc- Université Catholique de Louvain, Other |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Recurrent Disease, Squamous Cell Head and Neck Carcinoma, Palliative Treatment |
| Intervention type | Drug, Other |
| Interventions | biopsies, SU011248 |
| Enrollment | 54 |
| Start date | Feb 1, 2007 |
| Primary completion | Dec 1, 2011 |
| Completion | Dec 1, 2011 |
| First posted | Dec 6, 2006 |
| Last update posted | Sep 19, 2019 |
| Countries | Belgium, France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: